James Duncan, PhD, Joins Fox Chase Cancer Center as an Assistant Professor in the Cancer Biology Program
PHILADELPHIA, PA (August 9, 2013)—James Duncan, PhD, has joined Fox Chase Cancer Center’s Cancer Biology Program as an Assistant Professor. He recently completed a postdoctoral fellowship in the Department of Pharmacology at the University of North Carolina. His current work defines novel mechanisms for the rapid reprogramming of the kinome to targeted kinase inhibitors in preclinical models of triple negative breast cancer.
Dr. Duncan received his PhD from the University of Western Ontario, Canada. He has received many accolades for his work, including the Canadian Institutes of Health Research Postdoctoral Fellowship; Collip Award for top thesis in the School of Medicine and Dentistry; Canadian Institutes of Health Research award and Strategic Training Program in Cancer Research Award.
Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. For more information, call 1-888-FOX CHASE or (1-888-369-2427).